Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen M Davis

Showing results (341-350 of 414) with videos related to

Pageof 42
Sort By:
Cerebrovascular Diseases (Basel, Switzerland)|October 12, 2011
Fluid-attenuated inversion recovery hyperintensity in acute ischemic stroke may not predict hemorrhagic transformationBruce C V Campbell, Craig Costello, Søren Christensen, et al.
Neurology|November 25, 2024
Tranexamic Acid Within 4.5 Hours of Intracerebral Hemorrhage With the CTA Spot Sign: Systematic Review and Individual Patient Meta-analysisNawaf Yassi, Vignan Yogendrakumar, Leonid Churilov, et al.
Stroke|April 21, 2007
The Virtual International Stroke Trials ArchiveMyzoon Ali, Philip M W Bath, John Curram, et al.
Stroke|August 10, 2013
Validation of the DRAGON score in 12 stroke centers in anterior and posterior circulationDaniel Strbian, David J Seiffge, Lorenz Breuer, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 22, 2017
Cerebral blood volume lesion extent predicts functional outcome in patients with vertebral and basilar artery occlusionFana Alemseged, Darshan G Shah, Andrew Bivard, et al.
BMJ Open|April 29, 2022
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit-TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unitAndrew Bivard, Henry Zhao, Skye Coote, et al.
The Lancet. Neurology|February 26, 2008
Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trialStephen M Davis, Geoffrey A Donnan, Mark W Parsons, et al.
Annals of Neurology|November 17, 2022
Tenecteplase Improves Reperfusion across Time in Large Vessel StrokeVignan Yogendrakumar, James Beharry, Leonid Churilov, et al.
Stroke|December 4, 2010
EPITHET: Positive Result After Reanalysis Using Baseline Diffusion-Weighted Imaging/Perfusion-Weighted Imaging Co-RegistrationYoshinari Nagakane, Soren Christensen, Caspar Brekenfeld, et al.
Neurology|March 19, 2024
Association of Time to Thrombolysis With Early Reperfusion After Alteplase and Tenecteplase in Patients With Large Vessel OcclusionVignan Yogendrakumar, James Beharry, Leonid Churilov, et al.
Pageof 42

Showing results (341-350 of 414) with videos related to

Sort By:
Pageof 42
Cerebrovascular Diseases (Basel, Switzerland)|October 12, 2011
Fluid-attenuated inversion recovery hyperintensity in acute ischemic stroke may not predict hemorrhagic transformationBruce C V Campbell, Craig Costello, Søren Christensen, et al.
Neurology|November 25, 2024
Tranexamic Acid Within 4.5 Hours of Intracerebral Hemorrhage With the CTA Spot Sign: Systematic Review and Individual Patient Meta-analysisNawaf Yassi, Vignan Yogendrakumar, Leonid Churilov, et al.
Stroke|April 21, 2007
The Virtual International Stroke Trials ArchiveMyzoon Ali, Philip M W Bath, John Curram, et al.
Stroke|August 10, 2013
Validation of the DRAGON score in 12 stroke centers in anterior and posterior circulationDaniel Strbian, David J Seiffge, Lorenz Breuer, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 22, 2017
Cerebral blood volume lesion extent predicts functional outcome in patients with vertebral and basilar artery occlusionFana Alemseged, Darshan G Shah, Andrew Bivard, et al.
BMJ Open|April 29, 2022
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit-TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unitAndrew Bivard, Henry Zhao, Skye Coote, et al.
The Lancet. Neurology|February 26, 2008
Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trialStephen M Davis, Geoffrey A Donnan, Mark W Parsons, et al.
Annals of Neurology|November 17, 2022
Tenecteplase Improves Reperfusion across Time in Large Vessel StrokeVignan Yogendrakumar, James Beharry, Leonid Churilov, et al.
Stroke|December 4, 2010
EPITHET: Positive Result After Reanalysis Using Baseline Diffusion-Weighted Imaging/Perfusion-Weighted Imaging Co-RegistrationYoshinari Nagakane, Soren Christensen, Caspar Brekenfeld, et al.
Neurology|March 19, 2024
Association of Time to Thrombolysis With Early Reperfusion After Alteplase and Tenecteplase in Patients With Large Vessel OcclusionVignan Yogendrakumar, James Beharry, Leonid Churilov, et al.
Pageof 42